As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  2/4/22  J.W. Korth & Co., LP              X-17A-5    12/31/21    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  NYSE Arca, Inc.                   19B-4E       2/4/22    1:2K                                     SEC #7                   
  2/4/22  JPMorgan Chase Bank N… Depositary F-6EF        2/4/22    4:131K Vantage Towers AG/ADR             E-Data Systems, Inc./FA  
  2/4/22‡ Veritone, Inc.                    EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Lexaria Bioscience Corp.          EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ AIM ImmunoTech Inc.               EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Terawulf Inc.                     EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Ankam Inc.                        EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Medicine Man Technologies, Inc.   EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Todos Medical Ltd.                EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ American Rebel Holdings Inc.      EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ Creci Inc.                        QUALIF       2/4/22    1:2K                                     SEC #4                   
  2/4/22‡ Nuvectis Pharma, Inc.             EFFECT       2/4/22    1:2K                                     SEC #5                   
  2/4/22‡ ZA Group, Inc.                    QUALIF       2/4/22    1:2K                                     SEC #4                   
  2/4/22‡ Ses Ai Corp.                      EFFECT       2/4/22    1:2K                                     SEC #5                   

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	19B-4E	Info from a Self-Regulatory Organization (SRO) Listing and Trading a New Derivative Securities Product — Form 19b-4(e).
	EFFECT	SEC Notice of Effectiveness.
	F-6EF	Registration Statement – Depositary Shares Evidenced by American Depositary Receipts (ADRs) (Immediately Effective) — Form F-6.
	QUALIF	SEC Notice of Qualification.
	X-17A-5	Annual Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer — Form X-17A-5.